Technological changes can balance or recoup the investments made to create them. Amid pricing and market pressures, these opportunities and increases in resource efficiency can help enhance the patient experience and improve R&D potential and returns.
The latest immunosuppressant therapies are transforming the lives of patients in ways beyond physical success. Innovations in treatment not only help extend life, they can also reduce health care costs to give back confidence and hope to patients for the future.
A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.
The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors
Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.
A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six
Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affected. She had five children and was pregnant with her sixth when she was diagnosed with the disease.